A detailed history of Keybank National Association transactions in Dexcom Inc stock. As of the latest transaction made, Keybank National Association holds 8,732 shares of DXCM stock, worth $700,655. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,732
Previous 10,911 19.97%
Holding current value
$700,655
Previous $1.24 Million 52.71%
% of portfolio
0.0%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$64.0 - $116.06 $139,456 - $252,894
-2,179 Reduced 19.97%
8,732 $585,000
Q2 2024

Jul 31, 2024

BUY
$110.31 - $140.45 $213,229 - $271,489
1,933 Added 21.53%
10,911 $1.24 Million
Q1 2024

May 14, 2024

BUY
$114.22 - $140.1 $661,105 - $810,898
5,788 Added 181.44%
8,978 $1.25 Million
Q4 2023

Feb 13, 2024

BUY
$75.49 - $124.16 $14,116 - $23,217
187 Added 6.23%
3,190 $395,000
Q3 2023

Nov 08, 2023

SELL
$86.06 - $137.93 $144,666 - $231,860
-1,681 Reduced 35.89%
3,003 $280,000
Q2 2023

Aug 01, 2023

BUY
$112.47 - $130.98 $189,849 - $221,094
1,688 Added 56.34%
4,684 $601,000
Q1 2023

May 10, 2023

SELL
$104.0 - $122.92 $9,984 - $11,800
-96 Reduced 3.1%
2,996 $348,000
Q4 2022

Jan 31, 2023

SELL
$84.98 - $122.67 $22,179 - $32,016
-261 Reduced 7.78%
3,092 $350,000
Q3 2022

Oct 27, 2022

SELL
$76.35 - $94.18 $53,674 - $66,208
-703 Reduced 17.33%
3,353 $270,000
Q2 2022

Aug 08, 2022

BUY
$67.99 - $132.89 $227,358 - $444,384
3,344 Added 469.66%
4,056 $302,000
Q1 2022

Apr 28, 2022

SELL
$94.08 - $130.2 $53,343 - $73,823
-567 Reduced 44.33%
712 $364,000
Q4 2021

Feb 07, 2022

SELL
$129.87 - $162.82 $36,493 - $45,752
-281 Reduced 18.01%
1,279 $687,000
Q3 2021

Nov 08, 2021

SELL
$106.71 - $143.18 $6,509 - $8,733
-61 Reduced 3.76%
1,560 $853,000
Q2 2021

Aug 12, 2021

SELL
$80.99 - $107.93 $14,659 - $19,535
-181 Reduced 10.04%
1,621 $692,000
Q1 2021

May 07, 2021

BUY
$84.79 - $104.74 $508 - $628
6 Added 0.33%
1,802 $648,000
Q4 2020

Feb 09, 2021

BUY
$78.0 - $104.5 $71,526 - $95,826
917 Added 104.32%
1,796 $664,000
Q3 2020

Oct 29, 2020

BUY
$95.51 - $112.95 $2,769 - $3,275
29 Added 3.41%
879 $362,000
Q2 2020

Aug 10, 2020

BUY
$62.68 - $105.34 $5,077 - $8,532
81 Added 10.53%
850 $345,000
Q1 2020

May 13, 2020

BUY
$47.79 - $75.63 $36,750 - $58,159
769 New
769 $207,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Keybank National Association Portfolio

Follow Keybank National Association and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keybank National Association, based on Form 13F filings with the SEC.

News

Stay updated on Keybank National Association with notifications on news.